Israel Active

I reported previously on the non-invasive urine test of Israel’s Nucleix for monitoring bladder cancer treatment. Following a multi-center, 400-patients clinical trial, Nucleix has received the CE Mark allowing it to market Bladder EpiCheck in the E.U.

Dr. Michal Lotem is head of the Center for Melanoma and Cancer Immunotherapy at Hadassah Medical Center. Instead of going after the cancer, they target the immune system, boosting it to respond more aggressively to the disease.

Israel’s CorAlert is developing a non-invasive monitor that can diagnose heart failure in real-time. Sensors on the arm and chest, a pressure cuff and a proprietary algorithm estimate Left Ventricular End-Diastolic Pressure (LVEDP), an indicator of heart failure.  CorAlert’s CEO Amir Marmor explains on ILTV.

After her father suffered a brain injury, Israeli neuroscientist Son Preminger founded Intendu – which has developed motion-based adaptive video games for brain training and rehabilitation. These adapt in real time to the cognitive and physical abilities of the user.

When Israeli charity Ezer Mizion told a young law student she was a 100% bone marrow match for a 40-year-old female cancer patient, she jumped at the chance to save a life.  But the patient’s health deteriorated and the operation was canceled. Then one day, during law exams, another window opened to save the woman.

Eli Beer explains how the United Hatzalah model of life-saving has revolutionized the field of pre-ambulatory emergency care in Israel and the impact that it is making around the world. The latest 180 new ambucycles was the largest dedication of emergency vehicles in Israel’s history.

Israeli Life Sciences companies received $823 million in funds last year, representing 20% of all investments in Israeli high-tech. There are currently around 1,350 active life-sciences companies in Israel – of which 42% are in the medical devices sub-sector.

This video features two of Israel’s medical clowns - one Jewish and one Christian Arab - who bring relief and break down social barriers, one giant puffy red nose at a time. They may look silly, but they are revolutionizing the way Syrian refugees see Israel.

In a study of American male Jews over the age of 100, University of Haifa researchers have discovered a genetic mutation that affects the growth hormone receptor gene. Men with this mutation live on average 10 years longer than those without it.

Israel’s ReWalk has unveiled its prototype for a soft suit exoskeleton, to enable many of the millions with lower limb disabilities to walk upright. Initially, the new “Restore” suits will be used to assist stroke survivors, followed by multiple sclerosis patients.